PointState Capital’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

PointState Capital’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-100,000	Closed	-$4K	–	219
2018 Q1	$4K	Hold	100,000	–	–	﹤0.01%	151
2017 Q4	$2K	Hold	100,000	–	–	﹤0.01%	152
2017 Q3	$5K	Hold	100,000	–	–	﹤0.01%	152
2017 Q2	$9K	Hold	100,000	–	–	﹤0.01%	134
2017 Q1	$50K	Hold	100,000	–	–	﹤0.01%	133
2016 Q4	$79K	Hold	100,000	–	–	﹤0.01%	115
2016 Q3	$120K	Hold	100,000	–	–	﹤0.01%	153
2016 Q2	$45K	Buy	+100,000	New	+$52.6K	﹤0.01%	108

PointState Capital's ONSIZ Position: Q2 2018 in Review

PointState Capital sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 100,000 shares — an estimated $4K sold.

PointState Capital first reported a position in ONSIZ in Q2 2016 and held it in 8 quarters. The position peaked at $120K in Q3 2016. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

PointState Capital reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
PointState Capital sold 100,000 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $4K.
PointState Capital first reported a position in Oncobiologics, Inc. Series B Warrant in Q2 2016 and held it in 8 quarters.
PointState Capital's Oncobiologics, Inc. Series B Warrant position peaked at $120K in Q3 2016.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on PointState Capital's 13F filing for Q2 2018, filed 14 Aug 2018.